Directory
>
Scott Gottlieb
Scott Gottlieb
Board Member | New Enterprise Associates (NEA)
Washington, District of Columbia, United States
Scott Gottlieb
Summary
Scott Gottlieb, MD is a distinguished physician and former 23rd Commissioner of the U.S. Food and Drug Administration (FDA). He has a robust background in healthcare policy and regulation, focusing on innovative approaches to enhance medical outcomes and healthcare delivery. Dr. Gottlieb has played a pivotal role in advancing public health initiatives, overseeing significant reforms during his tenure at the FDA, including the approval of numerous novel therapies and medical devices. His strategic vision has also fostered advancements in gene therapies and digital health technologies. In addition to his regulatory work, he has experience in venture capital, serving as a partner at New Enterprise Associates, where he leverages his expertise to support healthcare startups. An accomplished author and commentator, he contributes to leading publications and regularly appears on major media platforms. His academic credentials include a medical degree from Mount Sinai School of Medicine and a background in economics from Wesleyan University, showcasing his interdisciplinary approach to healthcare challenges.
Scott Gottlieb
Work Experience
Board Member at
Xaira Therapeutics, Inc.
April 2024 - Present
Board Member at
Comanche Biopharma
January 2024 - Present
Board Member at
Resilience
October 2020 - Present
Board Member at
Illumina
February 2020 - Present
Board Member at
Tempus AI
October 2019 - Present
Board Member at
Aetion
September 2019 - Present
Member of the Board of Directors at
Pfizer, Inc.
May 2019 - Present
Elected Member at
National Academy of Medicine
October 2018 - Present
Partner at
New Enterprise Associates (NEA)
January 2007 - Present
Senior Fellow at
American Enterprise Institute
January 2003 - Present
Commissioner at
FDA
May 2017 - April 2019
Member of the Policy Board at
Society of Hospital Medicine
September 2011 - May 2017
Member Federal Health IT Policy Committee at
U.S. Department of Health and Human Services (HHS)
March 2013 - May 2017
Member of the Product Investment Board at
GSK
January 2010 - April 2017
Independent Member of the Board of Directors at
Daiichi Sankyo US
May 2015 - April 2017
Independent Member of the Board of Directors at
American Pathology Partners
March 2012 - April 2017
Clinical Assistant Professor at
NYU Langone Health
January 2011 - April 2017
Member of the Board of Directors at
Gradalis, Inc.
January 2015 - March 2017
Member of the Board of Directors at
Medavante-Prophase, Inc.
September 2007 - March 2017
Member of the Board of Directors at
Tolero Pharmaceuticals, Inc.
June 2015 - December 2016
Scott Gottlieb
Education
Mount Sinai School of Medicine of New York University, Resident
January 1999 - January 2002
Mount Sinai School of Medicine of New York University, Doctor Of Medicine (Md)
January 1995 - January 1999
January 1990 - January 1994
Frequently Asked Questions about Scott Gottlieb
What is Scott Gottlieb email address?
Scott Gottlieb's primary email address is **************@aei.org. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Scott Gottlieb work for?
Scott Gottlieb is a Board Member at New Enterprise Associates (NEA), a company specializing in Other Financial Investment Activities.
Where Scott Gottlieb graduated from?
Scott Gottlieb holds a degree in Internal Medicine Residency Program from Mount Sinai School of Medicine of New York University.
How can I directly contact Scott Gottlieb?
To contact Scott Gottlieb directly, you can use the email address **************@aei.org. Complete contact information is available upon registration with Muraena.
Who is Scott Gottlieb?
Scott Gottlieb, MD is a distinguished physician and former 23rd Commissioner of the U.S. Food and Drug Administration (FDA). He has a robust background in healthcare policy and regulation, focusing on innovative approaches to enhance medical outcomes and healthcare delivery. Dr. Gottlieb has played a pivotal role in advancing public health initiatives, overseeing significant reforms during his tenure at the FDA, including the approval of numerous novel therapies and medical devices. His strategic vision has also fostered advancements in gene therapies and digital health technologies. In addition to his regulatory work, he has experience in venture capital, serving as a partner at New Enterprise Associates, where he leverages his expertise to support healthcare startups. An accomplished author and commentator, he contributes to leading publications and regularly appears on major media platforms. His academic credentials include a medical degree from Mount Sinai School of Medicine and a background in economics from Wesleyan University, showcasing his interdisciplinary approach to healthcare challenges.
Scott`s contact details
**************@aei.org
*********@nam.edu
**************@pfizer.com
*********@toleropharma.com
*********@nea.com
Colleagues
President
Chairman Emeritus New Enterprise Associates
Managing Director, NEA UK
General Partner
Chairman, CEO & Chief Investment Officer
Chief Legal Officer
Managing Director
Chief Compliance Officer
Security Risk Assessment and Mitigation Consultant
Co-CEO